162 related articles for article (PubMed ID: 36271156)
1. Comparison of two methods for tumour-targeting peptide modification of liposomes.
Huang SQ; Zhang HM; Zhang YC; Wang LY; Zhang ZR; Zhang L
Acta Pharmacol Sin; 2023 Apr; 44(4):832-840. PubMed ID: 36271156
[TBL] [Abstract][Full Text] [Related]
2. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
3. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
4. Improved melanoma suppression with target-delivered TRAIL and Paclitaxel by a multifunctional nanocarrier.
Huang S; Zhang Y; Wang L; Liu W; Xiao L; Lin Q; Gong T; Sun X; He Q; Zhang Z; Zhang L
J Control Release; 2020 Sep; 325():10-24. PubMed ID: 32251770
[TBL] [Abstract][Full Text] [Related]
5. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer.
Xia T; He Q; Shi K; Wang Y; Yu Q; Zhang L; Zhang Q; Gao H; Ma L; Liu J
Pharm Dev Technol; 2018 Jan; 23(1):13-21. PubMed ID: 27884084
[TBL] [Abstract][Full Text] [Related]
6. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
[TBL] [Abstract][Full Text] [Related]
7. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
[TBL] [Abstract][Full Text] [Related]
10. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
[TBL] [Abstract][Full Text] [Related]
11. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency.
Li Z; Lu J; Tang B; Shi Y; Hai L; Guo L; Wu Y
Bioorg Med Chem; 2022 Apr; 60():116704. PubMed ID: 35286953
[TBL] [Abstract][Full Text] [Related]
12. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
[TBL] [Abstract][Full Text] [Related]
13. A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor
Yang Y; Tai X; Shi K; Ruan S; Qiu Y; Zhang Z; Xiang B; He Q
Theranostics; 2016; 6(12):2141-2160. PubMed ID: 27698946
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
15. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
[TBL] [Abstract][Full Text] [Related]
16. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
18. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]